Purple Biotech
PPBT
7 hedge funds and large institutions have $390K invested in Purple Biotech in 2017 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
17% more funds holding
Funds holding: 6 → 7 (+1)
0% less ownership
Funds ownership: 0% → 0% (-0%)
49% less capital invested
Capital invested by funds: $758K → $390K (-$368K)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VKH
Virtu KCG Holdings
New York
|
+$52.6K |
| 2 |
ARTA
A.R.T. Advisors
New York
|
+$23.9K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$23.9K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$14.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AG
Advisor Group
Phoenix,
Arizona
|
-$134K |
| 2 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$57K |
| 3 |
Creative Planning
Overland Park,
Kansas
|
-$24K |
| 4 |
MC
Menta Capital
San Francisco,
California
|
-$14.3K |
| 5 |
MIFH
Migdal Insurance & Financial Holdings
Petach Tikva,
Israel
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
MC
1
Menta Capital
San Francisco,
California
| $145K | -$14.3K | -3 | -7% |
|
2
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $108K | – | – | – |
|
|
VKH
3
Virtu KCG Holdings
New York
| $41K | +$52.6K | +11 | New |
|
|
AG
4
Advisor Group
Phoenix,
Arizona
| $39K | -$134K | -28 | -74% |
|
|
ARTA
5
A.R.T. Advisors
New York
| $21K | +$23.9K | +5 | New |
|
|
6
Citadel Advisors
Miami,
Florida
| $20K | +$23.9K | +5 | New |
|
|
7
UBS Group
Zurich,
Switzerland
| $15K | +$14.3K | +3 | +300% |
|
|
PVH
8
Psagot Value Holdings
Tel Aviv,
Israel
| $1K | – | – | – |
|
|
RJA
9
Raymond James & Associates
St Petersburg,
Florida
| – | -$57K | -9 | Closed |
|
|
10
Creative Planning
Overland Park,
Kansas
| – | -$24K | -4 | Closed |
|
|
MIFH
11
Migdal Insurance & Financial Holdings
Petach Tikva,
Israel
| – | -$1K | – | – |
|
PPBT Hedge Fund Activity: Q1 2017 in Review
7 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Purple Biotech (PPBT) for Q1 2017, worth a combined $390K — down 49% from $758K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new PPBT positions and 2 closed out — a net gain of 1 holder — while 1 added to existing stakes and 2 trimmed.
The largest buyer was Virtu KCG Holdings, opening a new position worth an estimated $52.6K. The largest seller was Advisor Group, cutting an estimated $134K.
- 7 institutional investors held Purple Biotech (PPBT) as of Q1 2017, up from 6 in Q4 2016.
- Funds reported $390K of Purple Biotech stock for Q1 2017, down 49% quarter-over-quarter.
- 3 funds opened new Purple Biotech positions in Q1 2017 and 2 closed out, a net change of +1 holder.
- The largest Purple Biotech buyer in Q1 2017 was Virtu KCG Holdings, an estimated $52.6K added.
- The largest Purple Biotech seller in Q1 2017 was Advisor Group, an estimated $134K sold.
Based on aggregated 13F filings for Q1 2017.